Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 1
2002 2
2010 1
2011 1
2018 2
2019 4
2020 2
2021 1
2022 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany.
Durno N, Arija P, Pantiri K, Heisen M, Boeri M, Paris J, Jack K, Chambenoit O, Subramanian R, Puelles J, Stolk E, van Hout B, Silverberg JI. Durno N, et al. Among authors: chambenoit o. J Dermatolog Treat. 2024 Dec;35(1):2417966. doi: 10.1080/09546634.2024.2417966. Epub 2024 Oct 27. J Dermatolog Treat. 2024. PMID: 39462516 Free article.
ABCA1 and the engulfment of apoptotic cells.
Hamon Y, Chambenoit O, Chimini G. Hamon Y, et al. Among authors: chambenoit o. Biochim Biophys Acta. 2002 Dec 30;1585(2-3):64-71. doi: 10.1016/s1388-1981(02)00325-6. Biochim Biophys Acta. 2002. PMID: 12531538 Review.
Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study.
Nguyen T, Churchill M, Levin R, Valenzuela G, Merola JF, Ogdie A, Orbai AM, Scher JU, Kavanaugh A, Kianifard F, Rollins C, Calheiros R, Chambenoit O. Nguyen T, et al. Among authors: chambenoit o. J Rheumatol. 2022 Aug;49(8):894-902. doi: 10.3899/jrheum.210912. Epub 2022 Apr 15. J Rheumatol. 2022. PMID: 35428722 Free article. Clinical Trial.
Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America.
Papp KA, Gooderham M, Beecker J, Lynde CW, Delorme I, Dei-Cas I, Albrecht L, Rampakakis E, Sampalis JS, Vieira A, Hussein S, Chambenoit O, Rihakova L. Papp KA, et al. Among authors: chambenoit o. BMC Dermatol. 2019 Jun 21;19(1):9. doi: 10.1186/s12895-019-0087-3. BMC Dermatol. 2019. PMID: 31226985 Free PMC article.
Secukinumab Efficacy on Psoriatic Arthritis GRAPPA-OMERACT Core Domains in Patients with or Without Prior Tumor Necrosis Factor Inhibitor Use: Pooled Analysis of Four Phase 3 Studies.
Orbai AM, Husni ME, Gladman DD, Leung YY, Siebert S, Tillett W, Vis M, Chambenoit O, Meng X, Mease PJ. Orbai AM, et al. Among authors: chambenoit o. Rheumatol Ther. 2021 Sep;8(3):1223-1240. doi: 10.1007/s40744-021-00337-5. Epub 2021 Jul 3. Rheumatol Ther. 2021. PMID: 34218429 Free PMC article.
16 results